<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A t(11;20)(p15;q11) is a rare but recurrent chromosomal aberration, reported in one case of <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera and a few cases of de novo <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>In t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases, the translocation resulted in the NUP98/TOP1 fusion transcript </plain></SENT>
<SENT sid="2" pm="."><plain>The NUP98 gene has been suggested as the target for therapy-related <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The reciprocal TOP1/NUP98 chimera, however, has not yet been encountered </plain></SENT>
<SENT sid="4" pm="."><plain>We report a further case of de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, subtype M2 in the French-American-British (FAB) classification, in which the reverse-transcriptase polymerase chain reaction (RT-PCR) revealed the NUP98/TOP1 chimera and also, for the first time, its reciprocal TOP1/NUP98 </plain></SENT>
<SENT sid="5" pm="."><plain>The literature review disclosed that, among six cases of de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with t(11;20), the NUP98 gene was shown to be involved in one case and the NUP98/TOP1 chimera was detected in another </plain></SENT>
<SENT sid="6" pm="."><plain>The translocation seems to be frequently associated with the <z:e sem="disease" ids="C0026999" disease_type="Neoplastic Process" abbrv="">FAB M2</z:e> subtype, younger age, hyperleukocytosis, and poor prognosis; thus, this translocation may identify a subset of not-therapy-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients with shared clinical features </plain></SENT>
</text></document>